BackTable / Urology / Podcast / Episode #101
Treating BPH with Rezum
with Dr. Seth Bechis
This week on the BackTable Urology Podcast, Dr. Jose Silva invites Dr. Seth Bechis onto the show to discuss the diagnosis and treatment of BPH with Rezum, a minimally invasive surgical that uses water vapor to dissolve prostate tissue.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2023, June 7). Ep. 101 – Treating BPH with Rezum [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Seth Bechis
Dr. Seth Bechis is a practicing urologist and associate professor with UC San Diego in California.
Dr. Jose Silva
Dr. Jose Silva is a board certified urologist practicing in Central Florida.
Synopsis
First, the doctors emphasize the importance of establishing a relationship between primary physicians and urologists to improve the referral times of patients with BPH. They also discuss how involving patients in the cystoscopy process can help them with the decision-making process and maintaining better bladder health in the long run.
Then, Dr. Bechis summarizes current BPH treatments, and how to effectively manage post-treatment patient expectations. He emphasizes the importance of over preparing patients for the potential side effects of BPH treatments, and strategies for adjusting their expectations. They also discuss the ideal candidates and prostate sizes for Rezum therapy. Additionally, Dr. Bechis discusses the technical aspects of the procedure, including his anesthesia regimen, needle placement, antibiotic prophylaxis, and postoperative care.
Finally, they explain the importance of following up on a PSA test annually after a prostate procedure and how to manage anxious patients who may be checking their PSA too frequently. As urologists, they have to counsel patients upfront about all of their options, so having flexibility to take different paths is helpful if their priorities change. Lastly, they touch on the idea of performing prophylactic procedures as a preventative measure.
This BackTable podcast is sponsored by Boston Scientific’s Urology Division. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world; this includes solutions for Benign Prostatic Hyperplasia or BPH, one of the most prevalent urologic conditions facing men today. [1,2]
Boston Scientific’s RezūmTM Water Vapor Therapy is a minimally invasive BPH treatment that provides urologists with an efficient, durable solution that reduces prostate volume while preserving sexual function. [3,4] With proven efficacy, durability, and lower clinical progression rates than daily medications, AUA guidelines support a shared decision-making process for the consideration of RezūmTM as a first-line treatment and alternative to medications. [3,5,6] Additionally, if insufficiently treated, BPH can negatively
impact bladder function, making earlier intervention valuable for patients. [7] Give your patients an alternative to daily medications and long-lasting BPH relief with Rezum Therapy.
1. AUA Annual Census Report – 2021, https://www.auanet.org/research-and-data/aua-census
2. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016
May 5;2:16031. doi: 10.1038/nrdp.2016.31. PMID: 27147135
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water
vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J
Urol. 2021 Sep;206(3):715-24.
4. Mynderse LA, Hanson D, Robb RA, et al. Rezūm System water vapor treatment for lower urinary tract symptoms/benign prostatic
hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional
renderings. Urology. 2015 Jul;86(1):122-7.
5. Gupta N, Rogers T, Holland B, et al. Three-year treatment outcomes of water vapor thermal therapy (Rezūm System) compared to
doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of
Prostatic Symptoms (MTOPS) Trial. J Urol. 2018 Aug;200(2):405-13.
6. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA
Guideline. J Urol 2021; 206: 806.
7. Mirone V, Imbimbo C, Longo N, Fusco F. The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Eur Uro. 2007, Vol 51
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-1540313-AA MAR 2023
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.